<DOC>
	<DOCNO>NCT02994537</DOCNO>
	<brief_summary>The purpose study explore pathogenes , clinical characteristic , laboratory histological examination result , treatment prognosis autoimmune hepatitis ( AIH ) . At phase 1 , investigator focus study clinical characteristic acute autoimmune hepatitis , study difference treatment effect acute autoimmune hepatitis chronic AIH . Morever , investigator notice drug induce AIH special characteristic may beneficial distinguish durg induce liver disease . Therefore investigator study drug induce AIH disease maybe related onset AIH .</brief_summary>
	<brief_title>Study Clinical Features Autoimmune Hepatitis</brief_title>
	<detailed_description>Now study research phase 1 , investigator focus study difference acute AIH chronic AIH . In phase , investigator analyse serum biochemical result ALT , AST , IgG , PT , INR , also compare histological performance . Finally , compare percentage biochemical remission two group , time initial treatment biochemical remission also put analysis . Now , investigator prepare submit manuscript phase 1 .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Autoimmune</mesh_term>
	<criteria>Clinical diagnosis autoimmune hepatitis Other cause liver disease , viral hepatitis , drug induce liver disease , primary biliary cirrhosis , primary sclerosing cholangitis , overlap syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>